Lars Henrik J.
- Country
- Denmark
- Department
- Vejle Sygehus
Research Overview
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- Evaluation of Targeted Anti-Cancer Therapy Using Vemurafenib and Drug Combinations in Patients with Advanced Cancer and Genomic Variants
- Phase 3 Randomized Study of Carboplatin-Paclitaxel with Retifanlimab vs. Placebo in Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal
Data & Insights
Has run more than one trial at 43 of 248 partner sites.
Specializations
Colorectal Cancer Research
Specializes in treating colorectal cancer with particular emphasis on investigating therapeutic approaches for patients with microsatellite instability high (MSI-H) and mismatch repair deficient metastatic conditions.
- Advanced Colon Cancer Treatment
- Neoadjuvant Therapy Strategies
- Locally Advanced Rectal Cancer Management
Focuses on comparing conventional treatment protocols with innovative therapeutic approaches in colorectal oncology.
Specialized Oncology
Conducts research in rare and specific cancer types, including squamous cell carcinoma of the anal canal and targeted treatments for advanced tumors.
- Anal Canal Carcinoma Treatment
- Advanced Tumor Management
- Immunotherapy Applications
Evaluates novel therapeutic combinations and treatment strategies for complex oncological conditions.
Precision Medicine
Leads investigations in genomic profiling-based cancer treatment, focusing on personalized therapeutic approaches using targeted anti-cancer medications.
- Genomic-Guided Therapy
- Targeted Drug Development
- Treatment Response Assessment
Implements innovative approaches in matching specific genomic variants with appropriate therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.